Purpose-built for physicians Oral quadruple receptor agonist confers weight loss with minimal GI adverse events Key takeaways: Adults with obesity lost 11.3% of body weight with 120 mg NA-931 and 13.8% with 150 mg NA-931 at 13 weeks
Antacids like Tums can help milder cases of reflux
Rodriguez, PhD, MPH Truveta, Inc , Bellevue, WA , Vincent Zhang Healthcare Transformation Institute, Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA, Samuel Gratzl, PhD Truveta, Inc , Bellevue, WA, Duy Do, PhD Truveta, Inc , Bellevue, WA, Brianna Goodwin Cartwright, MS Truveta, Inc , Bellevue, WA, , Charlotte Baker, DrPH, MPH, CPH Truveta, Inc , Bellevue, WA, Ty J
PLoS ONE 6(3): e18138